Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Cancer Excision Site”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02768337
What this trial is testing

Cambridge Brain Mets Trial 1

Who this might be right for
Lung CancerBreast CancerBrain Cancer+2 more
Cambridge University Hospitals NHS Foundation Trust 26
Testing effectiveness (Phase 2)Study completedNCT02970981
What this trial is testing

Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma

Who this might be right for
Melanoma
NYU Langone Health 18
Not applicableStudy completedNCT06415929
What this trial is testing

Etude rétrospective Monocentrique MATRIX

Who this might be right for
Melanoma
Centre Hospitalier Universitaire de Nice 15
Not applicableStudy completedNCT02434107
What this trial is testing

Complete Lymph Node Dissection vs Watchful Waiting in Patients With Malignant Melanoma (Thickness of 1,0mm+ and Evidence of Metastases in the Sentinel Node)

Who this might be right for
Melanoma
University Hospital Tuebingen 483
Not applicableUnknownNCT03683550
What this trial is testing

Comparing SLNE With or Without Preoperative Hybrid SPECT/CT in Melanoma

Who this might be right for
Melanoma
University Hospital, Essen 836
Early research (Phase 1)Study completedNCT03336606
What this trial is testing

Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaMelanoma+2 more
Providence Health & Services 13
Not applicableActive Not RecruitingNCT04385732
What this trial is testing

Melanoma Surveillance Photography (MSP) to Improve Early Detection of Melanoma in Ultra-high and High Risk Patients

Who this might be right for
MelanomaSkin CancerAnxiety and Fear
Melanoma and Skin Cancer Trials Limited 670
Testing effectiveness (Phase 2)Study completedNCT00199901
What this trial is testing

Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma

Who this might be right for
Melanoma
Ludwig Institute for Cancer Research 111
Post-approval studies (Phase 4)Study completedNCT00075166
What this trial is testing

Surgery Versus Radiosurgery to Treat Metastatic Brain Tumors

Who this might be right for
Brain NeoplasmsNeoplasm Metastasis
National Institute of Neurological Disorders and Stroke (NINDS) 130
Not applicableStudy completedNCT00597272
What this trial is testing

Determine Toxicity and Antibody Responses With a KLH Conjugated Bivalent Vaccine Containing GD2 Lactone, GD3 Lactone With Immunological Adjuvant QS-DG or OPT-821 in Patients With Disease Free AJCC Stage III or IV Cutaneous Melanoma

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 34
Testing effectiveness (Phase 2)UnknownNCT02817334
What this trial is testing

A Prospective Clinical Study for Evaluation of Safe Resection Margin in Breast Conserving Surgery in Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Center, Korea 149
Not applicableLooking for participantsNCT04543799
What this trial is testing

Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer

Who this might be right for
Prostate CancerBreast Cancer
Oncology Institute of Southern Switzerland 60
Testing effectiveness (Phase 2)Study completedNCT03405155
What this trial is testing

Nivolumab in Treating Patients With Stage IIB-IIC Melanoma That Can Be Removed by Surgery

Who this might be right for
Melanoma (Skin)
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 26
Not applicableStudy completedNCT00043472
What this trial is testing

Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk

Who this might be right for
Breast CancerOvarian Cancer
National Cancer Institute (NCI) 40
Early research (Phase 1)UnknownNCT03934827
What this trial is testing

MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour

Who this might be right for
MelanomaBreast CancerUterine Cancer+7 more
Imperial College London 120
Not applicableTemporarily pausedNCT04683120
What this trial is testing

Real-time Diagnosis and Visualization of Tumor Margins in Excised Breast Specimens Using Zenith FLIM Diagnostics

Who this might be right for
OncologyBreast CancerCancer Diagnosis+2 more
Laser LabCorp 100
Not applicableLooking for participantsNCT07354152
What this trial is testing

COmparison of the Use of a PERforator Flap Versus Total Skin GRAft in the Management of Loss of Substance After Resection of Cutaneous Melanoma - Pilot Study

Who this might be right for
Stage II Cutaneous Melanoma
Nantes University Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00085189
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeExtraocular Extension Melanoma+14 more
University of Southern California 42
Not applicableUnknownNCT04343079
What this trial is testing

Intra-operative PET-CT: a Novel Approach to Determine Excision Margins in Lumpectomy Breast Cancer.

Who this might be right for
Breast Cancer FemaleBreast Neoplasms
University Hospital, Ghent 100
Testing effectiveness (Phase 2)Study completedNCT00233974
What this trial is testing

Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 15
Next Page